Clinical Trial Update: IRS Proteins and Trastuzumab Resistance

View source ↗

Summary

A completed clinical study evaluating the role of IRS proteins in resistance to trastuzumab in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Breast Cancer | Status: COMPLETED